Aldeyra Therapeutics (NASDAQ:ALDX) Announces Earnings Results, Beats Expectations By $0.03 EPS
Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.30) by $0.03, reports. Aldeyra Therapeutics Price Performance Shares of NASDAQ:ALDX traded up $0.18 during trading on Friday, hitting $10.57. 660,942 shares of the company’s […]